Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease-Reference-Cited by-同舟云学术

Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease

Published:2022-10 Issue: Volume:173 Page:105854
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Rodríguez-Urgellés Ened,Rodríguez-Navarro Irene,Ballasch Iván,del Toro Daniel,del Castillo Ignacio,Brito Verónica,Alberch Jordi,Giralt Albert

Funder

Universitat de Barcelona

Agencia Estatal de Investigación

Ministerio de Ciencia e Innovación

Publisher

Elsevier BV

Subject

Neurology

Reference59 articles.

1. De novo variants in sporadic cases of childhood onset schizophrenia;Ambalavanan;Eur. J. Hum. Genet.,2016

2. Rootletin forms centriole-associated filaments and functions in centrosome cohesion;Bahe;J. Cell Biol.,2005

3. Inhibition of BET proteins during adolescence affects prefrontal cortical development: relevance to schizophrenia;Bilecki;Int. J. Mol. Sci.,2021

4. Neurotrophin receptor p75NTR mediates Huntington’s disease–associated synaptic and memory dysfunction;Brito;J. Clin. Invest.,2014

5. Cyclin-dependent kinase 5 dysfunction contributes to depressive-like behaviors in Huntington’s disease by altering the DARPP-32 phosphorylation status in the nucleus Accumbens;Brito;Biol. Psychiatry,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thalamic Foxp2 regulates output connectivity and sensory-motor impairments in a model of Huntington’s Disease;Cellular and Molecular Life Sciences;2023-11-21

2. Transcriptomic Characterization Reveals Disrupted Medium Spiny Neuron Trajectories in Huntington’s Disease and Possible Therapeutic Avenues;2023-05-01

3. Animal models of Huntington’s disease and their applicability to novel drug discovery and development;Expert Opinion on Drug Discovery;2023-04-11